nach oben

Journal of Neurology

Erschienen in:

26.04.2018 | Review

Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis

verfasst von: Thamina Rasul, Jette Lautrup Frederiksen

Erschienen in: Journal of Neurology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background/aims

The prevalence of overweight/obesity is a major problem in the world, and the number of MS cases is increasing. This literature study examines the relationship between overweight/obesity in children and adolescents and later occurrence of MS.

Method

This is a complete literature survey. The search database is primarily Pubmed using MeSH terms “multiple sclerosis”, “obesity”, and “overweight”, and text words not to restrict searches.

Results

All included studies show a link between being overweight/obese and the presence of MS among people below 20 years of age. The relation is especially true for young girls. The same relation in boys is not significant.

Conclusion

The literature survey convincingly revealed a link between young overweight/obese and occurrence of MS, in particular for girls. There is a need for more and larger studies to investigate the molecular mechanisms that link obesity and MS.

Nur mit Berechtigung zugänglich

https://sundhedsstyrelsen.dk/da/sundhed-og-livsstil/overvaegt. 28 Aug 2016

Harpsøe MC, Basit S, Andersson M, Nielsen NM, Frisch M, Wohlfahrt J, Nohr EA, Linneberg A, Jess T (2014) Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol 43(3):843–855CrossRef

Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269CrossRef

Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ (2014) Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology 83(11):1022–1024CrossRef

Feldt-Rasmussen U, Baslund Bo, Sørensen PS, Soelberg P, Søren F, Kastrup J. Lærebog i medicin FADL’s forlag 1, Udgave

Paulson Olaf B, Flemming G, Sørensen P. Klinisk neurologi og neurokirurgi FADL’s forlag 4, Udgave

Weissert R (2013) The immune pathogenesis of multiple sclerosis. J Neuroimmune Pharmacol 8(4):857–866CrossRef

Miller DH1, Chard DT, Ciccarelli O (2012) Clinically isolated syndromes. Lancet Neurol 11(2):157–169CrossRef

Corey-Bloom J, David RB. Clinical adult neurology, 3rd edn

10.

Munger KL, Chitnis T, Ascherio A (2009) Body size and risk of MS in two cohorts of US women. Neurology 73(19):1543–1550CrossRef

11.

Hedström AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18(9):1334–1336CrossRef

12.

Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TI, Baker JL (2013) Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 19(10):1323–1329CrossRef

13.

Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 80(6):548–552CrossRef

14.

Hedström AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, Olsson T, Alfredsson L (2014) Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology 82(10):865–872CrossRef

15.

Gianfrancesco MA, Acuna B, Shen L, Briggs FB, Quach H, Bellesis KH, Bernstein A, Hedstrom AK, Kockum I, Alfredsson L, Olsson T, Schaefer C, Barcellos LF (2014) Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obes Res Clin Pract 8(5):e435–e447CrossRef

16.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM (2015) Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler 21(4):388–395CrossRef

17.

Kavak KS, Teter BE, Hagemeier J, Zakalik K, Weinstock-Guttman B, New York State Multiple Sclerosis Consortium (2015) Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset. Mult Scler 21(7):858–865CrossRef

18.

Hedström AK, Olsson T, Alfredsson L (2016) Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler 22(7):878–883CrossRef

19.

Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838CrossRef

20.

Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690–693CrossRef

21.

Mai XM, Chen Y, Camargo CA Jr et al (2012) Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 175:1029–1036CrossRef

22.

Bäärnhielm M, Hedström AK, Kockum I, Sundqvist E, Gustafsson SA, Hillert J, Olsson T, Alfredsson L (2012) Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1* 15. Eur J Neurol 19(7):955–962CrossRef

23.

Aleksandrova K, Nimptsch K, Pischon T (2013) Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep 2:1–9CrossRef

24.

Nishimura S, Manabe I, Nagasaki M et al (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation on obesity. Nat Med 15:914–920

25.

Kasper LH, Shoemaker J (2010) Multiple sclerosis immunology: the healthy immune system vs. the MS immune system. Neurology 74(Suppl 1):S2–S8CrossRef

26.

Gøbel RJ, Jensen SM, Frøkiaer H et al (2012) Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paedatr 101:192–200CrossRef

27.

Emamgholipour SI, Sm E, Hossein-nezhad A, Mirzaei K, Maghbooli Z, Sahraian MA (2013) Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease. PLoS One 8(10):e76555CrossRef

28.

De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26(2):241–255CrossRef

29.

Kraszula L, Jasińska A, Eusebio M, Kuna P, Głąbiński A, Pietruczuk M (2012) Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis. Neurol Neurochir Pol 46(1):22–28

30.

Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901CrossRef

31.

Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S (2005) Leptin increase in multiple sclerosis associates with reduced number of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 102(14):5150–5155CrossRef

32.

Evangelopoulos ME, Koutsis G, Markianos M (2014) Serum leptin levels in treatment-naive patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis. Autoimmune Dis 2014:486282PubMedPubMedCentral

33.

Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T (2013) Increased leptin and A-FABP levels in relapsing and progressive forms of MS. BMC Neurol 13:172CrossRef

34.

Matarese G, Procaccini C, De Rosa V (2008) The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol 84(4):893–899CrossRef

35.

Hietaharju A, Kuusisto H, Nieminen R, Vuolteenaho K, Elovaara I, Moilanen E (2010) Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. Eur J Neurol 17(2):332–334CrossRef

36.

Natarajan R, Hagman S, Hämälainen M, Leppänen T, Dastidar P, Moilanen E, Elovaara I (2015) Adipsin is associated with multiple sclerosis: a follow-up study of adipokines. Mult Scler Int 2015:371734PubMedPubMedCentral

Titel: Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis
verfasst von: Thamina Rasul
Jette Lautrup Frederiksen
Publikationsdatum: 26.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 12/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8869-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis

Abstract

Background/aims

Method

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Background/aims

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research

Structural signature in SCA1: clinical correlates, determinants and natural history

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

A smartphone camera reveals an ‘invisible’ Parkinsonian tremor: a potential pre-motor biomarker?

Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status

Migraine prophylactic management in neurology and primary care (2006–2015)

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie